［1］Omid Veiseh，Forrest M Kievit，Jonathan W Gunn，et al.A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells［J］.Biomaterials，2009，30（4）：649-657.
［2］Chen LH，Jia ZY.Precision medicine-the problems about study on cancer gene delivery［J］.Journal of Practical Oncology，2015，30(06)：501-505.［陈丽红，贾振宇.精准医疗—肿瘤基因治疗研究关注的问题［J］.实用肿瘤杂志，2015，30（06）：501-505.］
［3］Dayananda Kasala，A-Rum Yoon，Jinwoo Hong，et al.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy［J］.Nanomedicine(Lond)，2016，11(13)：1689-1713.
［4］Xu J，Ganesh S，Amiji M.Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery［J］.Int J Pharm，2012，427(1)：21-34.
［5］Lu Yifei，Jiang Chen.Brain-targeted polymers for gene delivery in the treatment of brain diseases［J］.Top Curr Chem(Z)，2017，375：48-77.
［6］Mohammad R Abedi，Jo Wixon.Gene therapy clinical trials worldwide to 2007［J］.The Journal of Gene Medicine，2007，9(10)：833-842.
［7］Feigner PL，Gadek TR，Holm M，et al.Lipofection：A highly efficient lipid-mediated DNA transfection procedure［J］.Proc Natl Acad Sci USA，1987，84(21)：7413-7417.
［8］Zhao Yinan，Liu An，Du Yanyan，et al.Effects of sucrose ester structures on liposome-mediated gene delivery［EB/OL］.Acta Biomaterialia：ELSEVIER，（2018-3-15）［2018-4-23］.http：//pubmed.com/29609051.doi：10.1016/j.actbio.2018.03.031.
［9］Xia Yuqiong，Tian Jie，Chen Xiaoyuan.Effect of surface properties on liposomal siRNA delivery［J］.Biomaterials，2016，79：56-68.
［10］Stopeck AT，Jones A，Hersh EM，et al.Phase Ⅱ study of direct intralesional gene transfer of allovectin-7，an HLA-B7/2-microglobulin DNA-liposome complex，in patients with metastatic melanomal［J］.Clin Cancer Res，2001，7(8)：2285-2291.
［11］Evanthia Galanis，Patrick A Burch，Ronald L Richardson.Intratumoral administration of a 1，2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma［J］.Cancer，2004，101(11)：2557-2566.
［12］Junichi Yano，Kazuko Hirabayashi，Shin-ichiro Nakagawa，et al.Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer［J］.Clin Cancer Res，2004，10(15)：7721-7726.
［13］Solmaz Maleki Dizaj，Samira Jafari，Ahmad Yari Khosroushahi.A sight on the current nanoparticle-based gene delivery vectors［J］.Nanoscale Research Letters，2014，9(1)：252-261.
［14］Patil ML,Zhang M,Minko T，et al.Multifunctional triblock nanocarrier(PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing［J］.ACS Nano，2011，5(3)：1877-1887.
［15］Oh S，Rih J，Kwon H，et al.Lactoferrin as a gene delivery vehicle to hepatocytes［J］.Exp Mol Med，1997，29：111-116.
［16］Patnaik S，Tripathi SK，Goyal R,et al.Nanoparticle-based vectors for gene delivery［J］.Proc Natl Acad Sci India，2012，82( suppl 1)：59-81.
［17］Aied A，Greiser U，Pandit A，et al.Polymer gene delivery：Overcoming the obstacles［J］.Drug Discov Today，2013，18(21-22)：1090-1098.
［18］Brahmanand Dube，Abhijeet Pandey，Ganesh Joshi，et al.Cholic acid-modified polyethylenimine：In vitro and in vivo studies［J］.Int J Nanomedicine，2018，13：83-85.
［19］Wu Zhaoyong，Zhan Shuyu，Fan Wei，et al.Peptide-mediated tumor targeting by a degradable nano gene delivery vector based on pluronic-modified polyethylenimine［J］.Nanoscale Research Letters，2016，11(1)：122-135.
［20］Ren Henglei，Zhou Liang，Liu Min，et al.Peptide GE11-polyethylene glycol-polyethylenimine for targeted gene delivery in laryngeal cancer［J］.Med Oncol，2015，32：185-193.
［21］Nan Young Ahn，Tae-Hun Kim，Su Jeong Song，et al.Polyethylenimine-poly(amidoamine)dendrimer modified with l-arginines as an efficient gene delivery vector［J］.Macromolecular Research，2015，23(8)：726-733.
［22］Wang M，Liu H，Lei L，et al.A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios［J］.Nature Communications，2014，5：e4053.
［23］Qiu J，Kong L，Cao X，et al.Enhanced delivery of therapeutic siRNA into glioblastoma cells using dendrimer-entrapped gold nanoparticles conjugated with β-cyclodextrin［J］.Nanomaterials(Basel)，2018，8(3)：131-142.
［24］Caroline Diana Sherly M，Priya SS，Rekha MR.Particulate technology for delivery of therapeutics［M］.Singapore：Springer，2017：395-417.
［25］Maurstad G，Stokke BT，Varum KM，et al.PEGylated chitosan complexes DNA while improving polyplex colloidal stability and gene transfection efficiency［J］.Carbohydrate Polymers，2013，94(1)：436-443.
［26］Layek B，Singh J.Amino acid grafted CS for high performance gene delivery：Comparison of amino acid hydrophobicity on vector and polyplex characteristics［J］.Biomacromolecules，2013，14：485-494.
［27］Kim Jayoung，Wilson DR，Zamboni CG，et al.Targeted polymeric nanoparticles for cancer gene therapy［J］.J Drug Target，2015，23：627-641.
［28］Phatsapong Yingchoncharoen，Danuta S Kalinowski，Des R Richardson.Lipid-based drug delivery systems in cancer therapy：What is available and what is yet to come［J］.Pharmacological Reviews，2016，68(3)：701-787.
［29］Parvin F Peddi，Sara A Hurvitz.Trastuzumab emtansine：The first targeted chemotherapy for treatment of breast cancer［J］.2013，9(3)：319-326.
［30］Jonathan Fitzsimmons，Tapan Nayak，Cathy Cutler，et al.Synthesis and preliminary biological evaluations of fluorescent or 149Promethium labeled trastuzumab-polyethylenimine［J］.Biomedicines，2016，4(1)：1-12.
［31］Oliver Germershaus，Thomas Merdan，Udo Bakowsky，et al.Trastuzumab- polyethylenimine- polyethylene glycol conjugates for targeting her2-expressing tumors oliver［J］.Bioconjugate Chem，2006，17(5)：1190-1199.
［32］Xu Leyuan，Kittrell Shannon，Yeudall WA，et al.Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells［J］.Nanomedicine，2016，11(22)：2959-2973.
［33］Fu Shuang，Xu Xiaodong，Ma Yu，et al.RGD peptide based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy［EB/OL］.Journal of Drug Targeting：Taylor & Francis Group，(2018-3-22)［2018-4-23］.http：//pubmed.com/29564914.DOI：10.1080/1061186X.2018.1455841.
［34］Stefan J Riedl，Elena B Pasquale.Targeting the eph system with peptides and peptide conjugates［J］.Curr Drug Targets，2015，16(10)：1031-1047.
［35］Craik DJ，Fairlie DP，Liras S，et al.The future of peptide-based drugs［J］.Chem Biol Drug Des，2013，81：136-147.
［36］Yunching Chen，Dong-Yu Gao，Leaf Huang.In vivo delivery of miRNAs for cancer therapy：Challenges and strategies［J］.Adv Drug Deliv Rev，2015，81：128-141.